PPAR-alpha and -gamma but not -delta agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF-kappaB-independent effect
about
Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alphaPPARalpha and AP-2alpha regulate bombesin receptor subtype 3 expression in ozone-stressed bronchial epithelial cellsPPARalpha downregulates airway inflammation induced by lipopolysaccharide in the mouseDownregulation of peroxisome proliferator-activated receptors (PPARs) in nasal polyposisThe pathophysiological function of peroxisome proliferator-activated receptor-gamma in lung-related diseases.Thiazolidinediones and the risk of asthma exacerbation among patients with diabetes: a cohort study.Network analysis identifies a putative role for the PPAR and type 1 interferon pathways in glucocorticoid actions in asthmaticsPeroxisome proliferator-activated receptor alpha (PPAR alpha) down-regulation in cystic fibrosis lymphocytes.PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanismsMast cell involvement in the adenosine mediated airway hyper-reactivity in a murine model of ovalbumin-induced lung inflammationHaploinsufficiency for Stard7 is associated with enhanced allergic responses in lung and skin.PPARgamma as a new therapeutic target in inflammatory bowel diseasesNew anti-inflammatory therapies and targets for asthma and chronic obstructive pulmonary disease.PPARγ as a Potential Target to Treat Airway Mucus Hypersecretion in Chronic Airway Inflammatory Diseases.The Effect of PPAR Agonists on the Migration of Mature and Immature Eosinophils.Evaluation of the PPAR-γ Agonist Pioglitazone in Mild Asthma: A Double-Blind Randomized Controlled TrialPPARγ Ligands Regulate Noncontractile and Contractile Functions of Airway Smooth Muscle: Implications for Asthma Therapy.Pioglitazone is as effective as dexamethasone in a cockroach allergen-induced murine model of asthmaEffect of intranasal rosiglitazone on airway inflammation and remodeling in a murine model of chronic asthmaNew drugs targeting Th2 lymphocytes in asthma.Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?Peroxisome proliferator-activated receptor-gamma agonists as potential anti-inflammatory agents in asthma and chronic obstructive pulmonary disease.Anti- and proinflammatory effects of 15-deoxy-delta-prostaglandin J2(15d-PGJ2) on human eosinophil functions.Structural basis of human pregnane X receptor activation by the hops constituent colupulonePPARalpha and PPARgamma effectively protect against HIV-induced inflammatory responses in brain endothelial cellsPPAR-delta in Vascular Pathophysiology.Peroxisome proliferator-activated receptor gamma as a novel therapeutic target in asthma.Modulatory role for retinoid-related orphan receptor alpha in allergen-induced lung inflammation.Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease.Fenofibrate Attenuates Neutrophilic Inflammation in Airway Epithelia: Potential Drug Repurposing for Cystic Fibrosis.The impact of diet on asthma and allergic diseases.Activation of peroxisome proliferator-activated receptor-gamma in dendritic cells inhibits the development of eosinophilic airway inflammation in a mouse model of asthma.Quercetin attenuates inflammation in human macrophages and adipocytes exposed to macrophage-conditioned media.Peroxisome proliferator activated receptor ligands as regulators of airway inflammation and remodelling in chronic lung disease.Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor gamma and nuclear factor-kappaB in macrophages.Effect of peroxisome proliferator-activated receptor-gamma ligand on inflammation of human gallbladder epithelial cells.Thiazolidinediones inhibit airway smooth muscle release of the chemokine CXCL10: in vitro comparison with current asthma therapies.The modulation of PPARγ1 and PPARγ2 mRNA expression by ciglitazone in CD3/CD28-activated naïve and memory CD4+ T cells.PPARγ in dendritic cells and T cells drives pathogenic type-2 effector responses in lung inflammation.The effects of peroxisome proliferator-activated receptor-gamma agonist on a murine model of experimental allergic rhinitis.
P2860
Q23914416-C77940BE-5EB5-4719-9E03-E5F7F247E02CQ24669586-BCC3DDE8-9837-4809-AA2D-614F7BAECBE6Q24811747-CDCACD5E-B707-4B6B-BF35-D41A28FF0226Q24814458-AC8F822C-1F49-42FC-B4DD-E6E1E88AD437Q24814517-AFC95EA7-A90D-4B87-9050-9BEC4A4862DBQ33891499-15FF575D-EBE5-4DC8-BE8C-934A62DDAF93Q34309219-2312C8C1-8B6C-4F4B-8AFE-7B4F162181CBQ35021504-6EF42DE1-E5EC-468D-85A5-4EFB831CEA88Q35046094-B9C7594E-E020-486F-9653-DA25D45E4EFCQ35049057-869308DD-0FF0-4C22-B6D0-4597E6E561FBQ35691045-E1747A9A-F273-4C3C-834C-FAEA3CA60868Q35768913-F55FAE07-9F18-4027-81CE-F489E30AEAEFQ35842492-CE04BD46-2298-4965-BEF0-E3DD09B90A9FQ36065220-7AA61352-F03B-4DBA-8748-357929C70D14Q36090809-1A4BA34E-5F1A-4EB9-BA65-55DAD2D86DF0Q36112711-C4F0BB5D-D2C9-4E14-AFA2-8718ABB5EC46Q36200396-3A6F9656-5A84-46A2-9933-A50CF6CFFEACQ36440045-EBA636C8-6CB8-4EAC-9984-7849AC1B31B3Q36461169-D6FFC349-9818-4C5D-BC7D-1F4159011F4BQ36485165-D4F7BC4B-4DC2-44E9-B1B1-9560965FB87CQ36591722-BB27C63C-E943-4F8E-A9E5-B8D0ADCCEA8FQ36687379-488DEEB4-F2D1-4D79-8E62-74DC812DE8D9Q36836542-2DAC22B5-F068-408D-96BE-709D0F8E14B8Q36976887-2C31CC58-4EC3-4542-B132-A409A631FCC6Q37002797-07AA634F-39EB-48AD-A730-1E6D0B67DF81Q37037802-7007C38A-D687-434E-A97B-6A7F74A2C0E2Q37079967-4C3DCB01-6439-4B0E-8876-1AFB175574F7Q37110756-8D5E150D-983D-49B5-9636-8653524C69FAQ37447470-763F4DCA-9986-4DE7-9BE3-F2E0A051B981Q37700876-0EBDC663-D7FD-4BA4-9C42-1E65AF427EDCQ38439463-1852C995-E031-4372-B38C-C65E9F127346Q38584555-0C6417F1-CD06-4570-9FC9-AFF1D928B2E9Q39609098-ECB462F3-EC1E-43E5-B89A-BAE652569D9FQ39780799-376A5368-0DD2-4F4F-8A4D-088043B1D53FQ39990710-F3468356-E36E-4617-B8EE-22C30DE26C1BQ40820822-6C856F07-B2E6-42FE-817D-7872161B8B7EQ41681579-D6C08A01-32FA-40FE-A4E9-42C7A0A3CADFQ42550675-B2D9255E-61E7-4692-96EC-CDD25391A774Q46158421-4FAA2AE1-579E-4F6F-B2E5-39B41D28AD62Q46514221-93499840-E70C-4703-8017-0DEB19F4F5C7
P2860
PPAR-alpha and -gamma but not -delta agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF-kappaB-independent effect
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
PPAR-alpha and -gamma but not ...... n NF-kappaB-independent effect
@en
type
label
PPAR-alpha and -gamma but not ...... n NF-kappaB-independent effect
@en
prefLabel
PPAR-alpha and -gamma but not ...... n NF-kappaB-independent effect
@en
P2093
P2860
P356
P1476
PPAR-alpha and -gamma but not ...... n NF-kappaB-independent effect
@en
P2093
Alexandre Trifilieff
Anne Bench
Debbie Bayley
Emma Campbell
Marcus Hanley
Paul Whittaker
P2860
P304
P356
10.1038/SJ.BJP.0705232
P407
P577
2003-05-01T00:00:00Z